Venous thromboembolism (VTE) is one of the leading causes of morbidity and mortality in acutely ill medical patients. Fondaparinux is recommended for the prevention of VTE in this setting, but little information is available on its safety and effectiveness in unselected, "real world" patients. The aim of this paper was to assess the safety and efficacy of fondaparinux in elderly acutely ill medical patients.

Safety of fondaparinux in the prevention of venous thromboembolism in elderly medical patients: results of a single-center, retrospective study

AGENO, WALTER;
2014-01-01

Abstract

Venous thromboembolism (VTE) is one of the leading causes of morbidity and mortality in acutely ill medical patients. Fondaparinux is recommended for the prevention of VTE in this setting, but little information is available on its safety and effectiveness in unselected, "real world" patients. The aim of this paper was to assess the safety and efficacy of fondaparinux in elderly acutely ill medical patients.
2014
Acute Disease; Aged; Aged, 80 and over; Anticoagulants; Drug Administration Schedule; Female; Hemorrhage; Humans; Incidence; Inpatients; Italy; Male; Medical Records; Polysaccharides; Renal Insufficiency, Chronic; Retrospective Studies; Venous Thromboembolism
Silvestri, F; Pasca, S; Labombarda, A; Barbi, A; Desideri, M; Guidi, P; Rogato, A; Zaramella, M; Bergamo, M; Ageno, Walter; Barillari, G.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11383/2052022
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 4
social impact